Works by Sher, Taimur

Results: 63
    1

    AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma.

    Published in:
    Cancers, 2023, v. 15, n. 2, p. 477, doi. 10.3390/cancers15020477
    By:
    • Ailawadhi, Sikander;
    • Parrondo, Ricardo D.;
    • Dutta, Navnita;
    • Han, Bing;
    • Ciccio, Gina;
    • Cherukuri, Yesesri;
    • Alegria, Victoria R.;
    • LaPlant, Betsy R.;
    • Roy, Vivek;
    • Sher, Taimur;
    • Edwards, Brett;
    • Lanier, Stephanie;
    • Manna, Alak;
    • Heslop, Keisha;
    • Caulfield, Thomas;
    • Maldosevic, Emir;
    • Storz, Peter;
    • Manochakian, Rami;
    • Asmann, Yan;
    • Chanan-Khan, Asher A.
    Publication type:
    Article
    2
    3

    Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00721-6
    By:
    • Hampel, Paul J.;
    • Rabe, Kari G.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Leis, Jose F.;
    • Chanan-Khan, Asher A.;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Wang, Yucai;
    • Ailawadhi, Sikander;
    • Koehler, Amber B.;
    • Parrondo, Ricardo;
    • Schwager, Susan M.;
    • Sher, Taimur;
    • Hanson, Curtis A.;
    • Shi, Min;
    • Van Dyke, Daniel L.;
    • Braggio, Esteban;
    • Slager, Susan L.;
    • Kay, Neil E.
    Publication type:
    Article
    4

    Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 6, p. 1, doi. 10.1038/s41408-022-00680-y
    By:
    • Parrondo, Ricardo D.;
    • Rahman, Zaid Abdel;
    • Heckman, Michael G.;
    • Wieczorek, Mikolaj;
    • Jiang, Liuyan;
    • Alkhateeb, Hassan B.;
    • Litzow, Mark R.;
    • Greipp, Patricia;
    • Sher, Taimur;
    • Bergsagel, Leif;
    • Fonseca, Rafael;
    • Roy, Vivek;
    • Dispenzieri, Angela;
    • Kharfan-Dabaja, Mohamed A.;
    • Murthy, Hemant S.;
    • Ailawadhi, Sikander;
    • Foran, James M.
    Publication type:
    Article
    5
    6

    Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia.

    Published in:
    Blood Cancer Journal, 2019, v. 9, n. 10, p. N.PAG, doi. 10.1038/s41408-019-0237-1
    By:
    • Kumar, Vivek;
    • Ailawadhi, Sikander;
    • Bojanini, Leyla;
    • Mehta, Aditya;
    • Biswas, Suman;
    • Sher, Taimur;
    • Roy, Vivek;
    • Vishnu, Prakash;
    • Marin-Acevedo, Julian;
    • Alegria, Victoria R.;
    • Paulus, Aneel;
    • Aulakh, Sonikpreet;
    • Iqbal, Madiha;
    • Manochakian, Rami;
    • Tan, Winston;
    • Chanan-Khan, Asher;
    • Ailawadhi, Meghna
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14

    Efficacy of Daratumumab-Based Regimens for the Treatment of Plasma Cell Leukemia.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. 355, doi. 10.1016/j.clml.2021.01.002
    By:
    • Parrondo, Ricardo D.;
    • Moustafa, Muhamad Alhaj;
    • Reeder, Craig;
    • Sher, Taimur;
    • Roy, Vivek;
    • Muchtar, Eli;
    • Warsame, Rahma;
    • Alegria, Victoria;
    • Gonsalves, Wilson;
    • Dingli, David;
    • Hayman, Suzanne;
    • Kapoor, Prashant;
    • Chanan-Khan, Asher A.;
    • Ailawadhi, Sikander
    Publication type:
    Article
    15

    Trends in Early Mortality From Multiple Myeloma: A Population-Based Analysis.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. e449, doi. 10.1016/j.clml.2020.12.023
    By:
    • Kumar, Vivek;
    • Ailawadhi, Meghna;
    • Dutta, Navnita;
    • Abdulazeez, Mays;
    • Aggarwal, Chander Shekher;
    • Quintero, Gerson;
    • Baksh, Mizba;
    • Roy, Vivek;
    • Taimur Sher;
    • Alegria, Victoria;
    • Paulus, Aneel;
    • Chanan-Khan, Asher;
    • Ailawadhi, Sikander
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22

    Utilization of radiation therapy in multiple myeloma: trends and changes in practice.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 3, p. 735, doi. 10.1007/s00277-020-04371-1
    By:
    • Ailawadhi, Sikander;
    • Frank, Ryan;
    • Ailawadhi, Meghna;
    • Kanji, Zahara;
    • Jani, Prachi;
    • Fiala, Mark;
    • Abdulazeez, Mays;
    • Ahmed, Salman;
    • Aggarwal, Chander Shekher;
    • Aulakh, Sonikpreet;
    • Hodge, David;
    • Roy, Vivek;
    • Alegria, Victoria R.;
    • Paulus, Aneel;
    • Chanan-Khan, Asher;
    • Sher, Taimur
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30

    Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities.

    Published in:
    2018
    By:
    • Ailawadhi, Sikander;
    • Frank, Ryan D.;
    • Sharma, Mayank;
    • Menghani, Richa;
    • Temkit, M'hamed;
    • Paulus, Shumail;
    • Khera, Nandita;
    • Hashmi, Shahrukh;
    • Advani, Pooja;
    • Swaika, Abhisek;
    • Paulus, Aneel;
    • Aslam, Nabeel;
    • Sher, Taimur;
    • Roy, Vivek;
    • Colon‐Otero, Gerardo;
    • Chanan‐Khan, Asher;
    • Temkit, M'hamed;
    • Colon-Otero, Gerardo;
    • Chanan-Khan, Asher
    Publication type:
    journal article
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Targeting CD38 with daratumumab is lethal to Waldenström macroglobulinaemia cells.

    Published in:
    British Journal of Haematology, 2018, v. 183, n. 2, p. 196, doi. 10.1111/bjh.15515
    By:
    • Paulus, Aneel;
    • Manna, Alak;
    • Akhtar, Sharoon;
    • Paulus, Shumail M.;
    • Sharma, Mayank;
    • Coignet, Marie V.;
    • Jiang, Liuyan;
    • Roy, Vivek;
    • Witzig, Thomas E.;
    • Ansell, Stephen M.;
    • Allan, John;
    • Furman, Richard;
    • Aulakh, Sonikpreet;
    • Manochakian, Rami;
    • Ailawadhi, Sikander;
    • Chanan‐Khan, Asher A.;
    • Sher, Taimur
    Publication type:
    Article
    40
    41
    42
    43

    Biological effects and clinical significance of lenalidomide-induced tumour flare reaction in patients with chronic lymphocytic leukaemia: in vivo evidence of immune activation and antitumour response.

    Published in:
    British Journal of Haematology, 2011, v. 155, n. 4, p. 457, doi. 10.1111/j.1365-2141.2011.08882.x
    By:
    • Chanan-Khan, Asher A.;
    • Chitta, Kasyapa;
    • Ersing, Noreen;
    • Paulus, Aneel;
    • Masood, Aisha;
    • Sher, Taimur;
    • Swaika, Abhisek;
    • Wallace, Paul K.;
    • Mashtare, Terry L.;
    • Wilding, Greg;
    • Lee, Kelvin;
    • Czuczman, Myron S.;
    • Borrello, Ivan;
    • Bangia, Naveen
    Publication type:
    Article
    44

    A steroid-independent regimen of bortezomib, liposomal doxorubicin and thalidomide demonstrate high response rates in newly diagnosed multiple myeloma patients.

    Published in:
    British Journal of Haematology, 2011, v. 154, n. 1, p. 104, doi. 10.1111/j.1365-2141.2011.08703.x
    By:
    • Sher, Taimur;
    • Ailawadhi, Sikander;
    • Miller, Kena C.;
    • Manfredi, Debbie;
    • Wood, Margaret;
    • Tan, Wei;
    • Wilding, Gregory;
    • Czuczman, Myron S.;
    • Hernandez-Ilizaliturri, Francisco J.;
    • Hong, Fredrick;
    • Sood, Raman;
    • Soniwala, Saif;
    • Lawrence, William;
    • Jamshed, Saad;
    • Masood, Aisha;
    • Iancu, Daniel;
    • Lee, Kelvin;
    • Chanan-Khan, Asher
    Publication type:
    Article
    45
    46
    47
    48
    49
    50